A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Seagen Inc.
SOLTI Breast Cancer Research Group
Memorial Sloan Kettering Cancer Center
The Methodist Hospital Research Institute
University of Florida